KIM-1 kidney injury
Selected indexed studies
- KIM-1 mediates fatty acid uptake by renal tubular cells to promote progressive diabetic kidney disease. (Cell Metab, 2021) [PMID:33951465]
- Kidney Injury Molecule 1 (KIM-1): a Multifunctional Glycoprotein and Biological Marker (Review). (Sovrem Tekhnologii Med, 2021) [PMID:34603757]
- Kidney injury molecule-1. (Curr Opin Crit Care, 2010) [PMID:20930626]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- KIM-1 mediates fatty acid uptake by renal tubular cells to promote progressive diabetic kidney disease. (2021) pubmed
- Kidney Injury Molecule 1 (KIM-1): a Multifunctional Glycoprotein and Biological Marker (Review). (2021) pubmed
- Kidney injury molecule-1. (2010) pubmed
- Current concepts and advances in biomarkers of acute kidney injury. (2021) pubmed
- Kidney Injury Molecule-1 (KIM-1): a specific and sensitive biomarker of kidney injury. (2008) pubmed
- Therapeutic α-1-microglobulin ameliorates kidney ischemia-reperfusion injury. (2024) pubmed
- Kim-1-targeted multimodal nanoprobes for early diagnosis and monitoring of sepsis-induced acute kidney injury. (2025) pubmed
- The Predictive Role of the Biomarker Kidney Molecule-1 (KIM-1) in Acute Kidney Injury (AKI) Cisplatin-Induced Nephrotoxicity. (2019) pubmed
- APOBEC-1 deletion enhances cisplatin-induced acute kidney injury. (2023) pubmed
- Kidney injury molecule-1 in kidney disease. (2016) pubmed